SSgA SPDR S&P Developed Quality Aristocrats UCITS ETF (ETR:QDEV)
9.35
-0.26 (-2.73%)
At close: Aug 1, 2025, 5:30 PM CET
-2.73% (1Y)
Assets | 37.12M |
Expense Ratio | 0.38% |
PE Ratio | 28.03 |
Dividend (ttm) | n/a |
Dividend Yield | n/a |
Ex-Dividend Date | n/a |
Payout Frequency | n/a |
Payout Ratio | n/a |
1-Year Return | n/a |
Volume | 15,574 |
Open | 9.53 |
Previous Close | 9.61 |
Day's Range | 9.26 - 9.53 |
52-Week Low | 7.59 |
52-Week High | 10.15 |
Beta | n/a |
Holdings | 111 |
Inception Date | Dec 6, 2024 |
About QDEV
QDEV.L was created on 2024-12-06 by SPDR. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 36.47m in AUM and 100 holdings. The investment objective of the Fund is to track the performance of large and mid-sized equities in developed markets (as such term is defined by the Index Provider) globally (Developed Markets).
Asset Class Equity
Category Total Market
Stock Exchange Deutsche Börse Xetra
Ticker Symbol QDEV
Provider SPDR
Index Tracked S&P Developed Quality FCF Aristocrats Index - Benchmark TR Net
Top 10 Holdings
49.17% of assetsName | Symbol | Weight |
---|---|---|
Broadcom Inc. | AVGO | 6.61% |
NVIDIA Corporation | NVDA | 6.59% |
Microsoft Corporation | MSFT | 5.78% |
Meta Platforms, Inc. | META | 5.58% |
ASML Holding N.V. | ASML | 4.86% |
Roche Holding AG | ROG | 4.79% |
Apple Inc. | AAPL | 4.41% |
Visa Inc. | V | 3.65% |
Mastercard Incorporated | MA | 3.47% |
Novo Nordisk A/S | NOVO.B | 3.42% |